Key statistics
As of last trade, Gyre Therapeutics Inc (L9S:FRA) traded at 12.70, 170.67% above the 52 week low of 4.69 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.70 |
---|---|
High | 12.70 |
Low | 12.70 |
Bid | 12.50 |
Offer | 12.70 |
Previous close | 12.70 |
Average volume | 0.00 |
---|---|
Shares outstanding | 93.42m |
Free float | 23.53m |
P/E (TTM) | -- |
Market cap | 1.31bn USD |
EPS (TTM) | -0.8638 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 07:06 BST.
More ▼
Announcements
- Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
- Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
- Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
- Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
- Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
- Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
- Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
- Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
More ▼